Hydrogen sulfide preconditioning or neutrophil depletion attenuates Ischemiareperfusion-induced mitochondrial dysfunction in rat small intestine

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 302, Issue 1, 2012, Pages

  Liu, Yajun ^a   Kalogeris, Theodore ^a   Wang, Meifang ^a   Zuidema, Mozow Zuidema ^a,b   Wang, Qun ^a   Dai, Hongyan ^a   Davis, Michael J ^a,b   Hill, Michael A ^a   Korthuis, Ronald J ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Anti neutrophil serum; Calcium activated potassium channels; Cytochrome c release; Ileum; Large conductance; Mitochondrial membrane potential; Mitochondrial respiration; Myeloperoxidase; Rats; TNF

Indexed keywords

CYTOCHROME C; HYDROGEN SULFIDE; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MYELOPEROXIDASE; POTASSIUM CHANNEL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; ISCHEMIC PRECONDITIONING; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY; WESTERN BLOTTING;

ANIMALS; BENZIMIDAZOLES; CYTOCHROMES C; HYDROGEN SULFIDE; INTESTINAL DISEASES; INTESTINE, SMALL; ISCHEMIC PRECONDITIONING; LEUKOCYTE REDUCTION PROCEDURES; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NEUTROPHILS; PEROXIDASE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SULFIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83755177785     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00413.2010     Document Type: Article

References (67)

1. Boehning D, Snyder S. Novel neural modulators. Annu Rev Neurosci 26: 105-131, 2003.
2. Bolli R. Preconditioning: a paradigm shift in the biology of myocardial ischemia. Am J Physiol Heart Circ Physiol 292: H19-H27, 2007.
3. Cho J, Won K, Wu D, Soong Y, Liu S, Szeto HH, Hong MK. Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron Artery Dis 18: 215-220, 2007.
4. Cooper D, Russell J, Chitman KD, Williams MC, Wolf RE, Granger DN. Leukocyte dependence of platelet adhesion in postcapillary venules. Am J Physiol Heart Circ Physiol 286: H1895-H1900, 2004.
5. Douglas RM, Lai JC, Bian S, Cummins L, Moczydlowski E, Haddad GG. The calcium-sensitive large-conductance potassium channel (BK/ MAXI K) is present in the inner mitochondrial membrane of rat brain. Neuroscience 139: 1249-1261, 2006.
6. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104: 15560-15565, 2007.
7. Essin K, Salanova B, Kettritz R, Sausbier M, Luft FC, Kraus D, Bohn E, Autenrieth IB, Peschel A, Ruth P, Gollasch M. Large-conductance calcium-activated potassium channel activity is absent in human and mouse neutrophils and is not required for innate immunity. Am J Physiol Cell Physiol 293: C45-C54, 2007.
8. Fu Z, Liu X, Geng B, Fang L, Tang C. Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. Life Sci 82: 1196-1202, 2008.
9. Gaskin FS, Kamada K, Yusof M, Korthuis RJ. 5=-AMP-activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 292: H326-H332, 2007.
10. Gaskin FS, Kamada K, Yusof M, Durante W, Gross G, Korthuis RJ. AICAR preconditioning prevents postischemic leukocyte rolling and adhesion: role of KATP channels and heme oxygenase. Microcirculation 16: 167-176, 2009.
11. Gáspár T, Katakam P, Snipe JA, Kis B, Domoki F, Bari F, Busija DW. Delayed neuronal preconditioning by NS1619 is independent of calcium activated potassium channels. J Neurochem 105: 1115-1128, 2008.
12. Ghatta S, Nimmagadda D, Xu X, O'Rourke ST. Calcium-activated potassium channels: structural and functional implications. Pharmacol Ther 110: 103-116, 2006.
13. Gross ER, Gross GJ. Ischemic preconditioning and myocardial infarction: an update and perspective. Drug Discov Today Dis Mech 4: 165-174, 2007.
14. Huffmyer J, Raphael J. Physiology and pharmacology of myocardial preconditioning and postconditioning. Semin Cardiothorac Vasc Anesth 13: 5-18, 2009.
15. Jha S, Calvert JW, Duranski MR, Ramachandran A, Lefer DJ. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol 295: H801-H806, 2008.
16. Johansen D, Ytrehus K, Baxter GF. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury - evidence for a role of KATP channels. Basic Res Cardiol 101: 53-60, 2006.
17. Kamada K, Dayton CB, Yamaguchi T, Korthuis RJ. Antecedent ethanol ingestion prevents postischemic microvascular dysfunction. Pathophysiology 10: 131-137, 2004.
18. Kamada K, Gaskin FS, Yamaguchi T, Carter P, Yoshikawa T, Yusof M, Korthuis RJ. Role of calcitonin gene-related peptide in the postischemic anti-inflammatory effects of antecedent ethanol ingestion. Am J Physiol Heart Circ Physiol 290: H531-H537, 2006.
19. Kimura H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem Biophys Res Commun 267: 129-133, 2000.
20. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K. "Ischemic tolerance" phenomenon found in the brain. Brain Res 528: 21-24, 1990.
21. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163, 2007.
22. Krotz F, Riexinger T, Buerkle MA, Nithipatikom K, Gloe T, Sohn HY, Campbell WB, Pohl U. Membrane potential-dependent inhibition of platelet adhesion to endothelial cells by epoxysatrienoic acids. Arterioscler Thromb Vasc Biol 24: 595-600, 2004.
23. Kulawiak B, Kudin AP, Szewczyk A, Kunz WS. BK channel openers inhibit ROS production of isolated rat brain mitochondria. Exp Neurol 212: 573-547, 2008.
24. Kurtel H, Fujimoto K, Zimmerman BJ, Granger DN, Tso P. Ischemiareperfusion- induced mucosal dysfunction: role of neutrophils. Am J Physiol Gastrointest Liver Physiol 261: G490-G496, 1991.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
26. Liu H, Bai XB, Shi S, Cao YX. Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats. J Pharm Pharmacol 61: 207-212, 2009.
27. Masola B, Evered DF. Preparation of rat enterocyte mitochondria. Biochem J 218: 441-447, 1984.
28. + channel in the basolateral membrane of rat enterocytes. FEBS Lett 206: 87-92, 1986.
29. Mustafa AK, Gadalla MM, Snyder SH. Signaling by gasotransmitters. Sci Signal 2: re2, 2009.
30. Nardi A, Calderone V, Chericoni S, Morelli I. Natural modulators of large-conductance calcium-activated potassium channels. Planta Med 69: 885-892, 2003.
31. Narenjkar J, Marsh SJ, Assem ESK. Inhibition of antigen-induced activation of RBL-2H3 cells by charybdotoxin and cetiedil. Eur J Pharmacol 483: 95-106, 2004.
32. + channels in cardiac mitochondria. Am J Physiol Heart Circ Physiol 289: H1635-H1642, 2005.
33. Pan TT, Feng ZN, Lee SW, Moore PK, Bian JS. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol 40: 119-130, 2006.
34. Perez-Pinzon MA. Neuroprotective effects of ischemic preconditioning in brain mitochondria following cerebral ischemia. J Bioenerg Biomembr 36: 323-327, 2004.
35. Salter JW, Krieglstein CF, Issekutz AC, Granger DN. Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation. Am J Physiol Gastrointest Liver Physiol 281: G1432-G1439, 2001.
36. + channels in cardiac myocytes: a mechanism of the cardioprotective effect and modulation by protein kinase A. Circulation 111: 198-203, 2005.
37. Shanmuganathan S, Hausenloy DJ, Duchen MR, Yellon DM. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 289: H237-H242, 2005.
38. Shigematsu S, Ishida S, Gute DC, Korthuis RJ. Postischemic antiinflammatory effects of bradykinin preconditioning. Am J Physiol Heart Circ Physiol 280: H441-H454, 2001.
39. Sitdikova GF, Weiger TM, Hermann A. Hydrogen sulfide increases calcium-activated potassium (BK) channel activity of rat pituitary tumor cells. Pflügers Arch 459: 389-397.
40. + channel opening requires superoxide radical generation. Am J Physiol Heart Circ Physiol 290: H434-H440, 2006.
41. Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935, 2007.
42. Takeyoshi I, Zhang S, Nomoto M, Zhu Y, Kokudo Y, Suzuki T, Hamada N, Nemoto A, Starzl TE, Todo S. Mucosal damage and recovery of the intestine after prolonged preservation and transplantation in dogs. Transplantation 71: 1-7, 2001.
43. Tripatara P, Patel PN, Collino M, Gallicchio M, Kieswich J, Castiglia S, Benetti E, Stewart KN, Brown PA, Yaqoob MM, Fantozzi R, Thiemermann C. Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 88: 1038-1048, 2008.
44. Vergara C, Latorre R, Marrion NV, Adelman JP. Calcium-activated potassium channels. Curr Opin Neurobiol 8: 321-329, 1998.
45. Walkinshaw M, Downey D, Gottlieb JR, Engrav LH. Ischemic injury to enteric free flaps: an experimental study in the dog. Plast Reconstr Surg 81: 939-945, 1988.
46. Wallace JL. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 28: 501-505, 2007.
47. + channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice. Am J Physiol Heart Circ Physiol 287: H2070-H2077, 2004.
48. + channels in smooth muscle cells. J Gen Physiol 110: 35-44, 1997.
49. Whiteman M, Armstrong J, Chu SH, Jia-Ling S, Wong BS, Cheung NS, Halliwell B, Moore PK. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J Neurochem 90: 765-768, 2004.
50. Whiteman M, Cheung N, Zhu YZ, Chu SH, Siau JL, Wong BS, Armstrong JS, Moore PK. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem Biophys Res Commun 326: 794-798, 2005.
51. + channels as therapeutic drug targets. Pharmacol Ther 94: 157-182, 2002.
52. + channels inhibits proliferation of human endothelial cells induced by basic fibroblast growth factor. J Vasc Res 35: 363-371, 1998.
53. Wieckowski MR, Giorgi C, Lebiedzinska M, Duszynski J, Pinton P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat Protoc 4: 1582-1590, 2009.
54. Wu B, Ootani A, Iwakiri R, Fujise T, Tsunada S, Toda S, Fujimoto K. Ischemic preconditioning attenuates ischemia-reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine. Am J Physiol Gastrointest Liver Physiol 286: G580-G587, 2004.
55. Xia XM, Zeng X, Lingle CJ. Multiple regulatory sites in large-conductance calcium-activated potassium channels. Nature 418: 880-884, 2002.
56. + channels in the cardiac inner mitochondrial membrane. Science 298: 1029-1033, 2002.
57. Yamaguchi T, Kamada K, Dayton C, Gaskin FS, Yusof M, Yoshikawa T, Carter P, Korthuis RJ. Role of eNOS-derived NO in postischemic anti-inflammatory effects of antecedent ethanol ingestion in murine small intestine. Am J Physiol Heart Circ Physiol 292: H1435-H1442, 2007.
58. Yamaguchi T, Dayton C, Shigematsu T, Carter P, Yoshikawa T, Gute DC, Korthuis RJ. Preconditioning with ethanol prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 283: H1019-H1030, 2002.
59. Yonezawa D, Sekiguchi F, Miyamoto M, Taniguchi E, Honjo M, Masuko T, Nishikawa H, Kawabata A. A protective role of hydrogen sulfide against oxidative stress in rat gastric mucosal epithelium. Toxicology 241: 11-18, 2007.
60. Yusof M, Kamada K, Kalogeris T, Gaskin FS, Korthuis RJ. Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- and p38 MAPK-dependent mechanism. Am J Physiol Heart Circ Physiol 296: H868-H876, 2009.
61. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocytemediated inflammation. FASEB J 20: 2118-2120, 2006.
62. Zhang H, Zhi L, Moochhala S, Moore PK, Bhatia M. Hydrogen sulfide acts as an upstream inflammatory mediator in cecal ligation and punctureinduced sepsis in mice by upregulating the production of cytokines and chemokines via NF-B. Am J Physiol Lung Cell Mol Physiol 292: L960-L971, 2007.
63. Zhao W, Wang R. H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283: H474- H480, 2002.
64. Zhou XB, Arntz C, Kamm S, Motejlek K, Sausbier U, Wang GX, Ruth P, Korth M. A molecular switch for specific stimulation of the BKCa channel by cGMP and cAMP kinase. J Biol Chem 276: 43239- 43245, 2001.
65. Zhu YZ, Wang ZJ, Ho P, Loke YY, Zhu YC, Huang SH, Tan CS, Whiteman M, Lu J, Moore PK. Hydrogen sulfide and its cardioprotective effects in myocardial ischemia in experimental rats. J Appl Physiol 102: 261-268, 2007.
66. Zuidema M, Yang Y, Wang M, Kalogeris T, Liu Y, Meininger CJ, Hill MA, Davis MJ, Korthuis RJ. Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of BK channels. Am J Physiol Heart Circ Physiol 299: H1554-H1567, 2010.
67. Zuidema MY, Peyton KJ, Fay WP, Durante W, Korthuis RJ. Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of heme oxygenase-1. Am J Physiol Heart Circ Physiol 301: H388-H394, 2011.